NCT03139591View on ClinicalTrials.gov

Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone in Reducing Pain After Laryngeal Mask Insertion

NACompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

May 31, 2017

Conditions
Adult Patients Undergoing Elective Surgery With General Anesthesia and LMA Insertion
Interventions
DRUG

lidocaine inhalation; intravenous dexamethasone

1.5 mg/kg body weight (BW) of 2% lidocaine inhalation, diluted with 2-3 ml of normal saline until the total volume was 6 ml, and intravenous normal saline injection; Intravenous dexamethasone group: normal saline inhalation and 10 mg of intravenous dexamethasone.

Trial Locations (1)

10430

Cipto Mangunkusumo Central National Hospital, Central Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT03139591 - Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone in Reducing Pain After Laryngeal Mask Insertion | Biotech Hunter | Biotech Hunter